Sector revisions BeOne Medicines AG

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 06/06/2026 am IST			5-day change	1st Jan Change
270.10 ^USD	-3.51%		-6.19%	-11.10%

02/06	BeOne Medicines Solid Tumor Data Boost Confidence in Long-term Growth, RBC Says	MT
02/06	RBC Raises Price Target on BeOne Medicines to $436 From $425, Keeps Outperform Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Visibility	Nbr of analysts
BEONE MEDICINES AG				28
LONZA GROUP AG				23
REVOLUTION MEDICINES, INC.				21
IQVIA HOLDINGS INC.				20
CELLTRION, INC.				24
EUROFINS SCIENTIFIC SE				14
ASCENDIS PHARMA A/S	-	-		17
MEDPACE HOLDINGS, INC.				12
IONIS PHARMACEUTICALS, INC.				25
ICON PUBLIC LIMITED COMPANY				16
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.				15
BLUEPRINT MEDICINES CORPORATION			-	-
TEMPUS AI, INC.				15
BIO-TECHNE CORPORATION				12
ABIVAX				7
QIAGEN N.V.				14
ALKERMES PLC				16
PRAXIS PRECISION MEDICINES, INC.				17
ARCELLX, INC.			-	-
Average				17
Weighted average by Cap.				20